2024
Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination
Vesco K, Denoble A, Lipkind H, Kharbanda E, DeSilva M, Daley M, Getahun D, Zerbo O, Naleway A, Jackson L, Williams J, Boyce T, Fuller C, Weintraub E, Vazquez-Benitez G. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics And Gynecology 2024, 143: 794-802. PMID: 38626447, PMCID: PMC11090513, DOI: 10.1097/aog.0000000000005583.Peer-Reviewed Original ResearchMeSH KeywordsAdultCOVID-19COVID-19 VaccinesFemaleHumansInfant, NewbornInfant, Small for Gestational AgePregnancyPregnancy Complications, InfectiousPregnancy OutcomePremature BirthRetrospective StudiesSARS-CoV-2VaccinationYoung AdultConceptsSmall-for-gestational ageMessenger RNA COVID-19 vaccineGestational diabetes mellitusRisk of adverse pregnancy outcomesAdverse pregnancy outcomesPreterm birthGestational hypertensionAdjusted hazard ratiosCOVID-19 vaccine dosesPregnancy outcomesCOVID-19 vaccineAssociated with small-for-gestational ageIncreased risk of adverse pregnancy outcomesVaccine doseRisk of preterm birthMessenger RNARetrospective cohort study of individualsMRNA COVID-19 vaccineWeeks of gestationRetrospective cohort studyHistory of COVID-19Cohort study of individualsVaccine Safety DatalinkSingleton pregnanciesUnexposed pregnancies
2020
Lower Urinary Pathogens: Do More Pathogenic Bacteria Increase the Risk of Pyelonephritis?
Rosett HA, Krischak MK, Sachdeva S, Weaver KE, Heine RP, Denoble AE, Dotters-Katz SK. Lower Urinary Pathogens: Do More Pathogenic Bacteria Increase the Risk of Pyelonephritis? American Journal Of Perinatology 2020, 39: 473-478. PMID: 32971563, DOI: 10.1055/s-0040-1717093.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsBacteriaEscherichia coliFemaleHumansInfant, NewbornMalePre-EclampsiaPregnancyPregnancy Complications, InfectiousPremature BirthPyelonephritisRetrospective StudiesUrinary Tract InfectionsConceptsLower urinary tract infectionsHistory of preeclampsiaPreterm birthPregnant womenLow birthweightPathogenic infectionsOutside of pregnancyRisk of pyelonephritisOdds of progressionSingle tertiary centerPreterm birth rateRisk of progressionUrinary tract infectionBody mass indexRate of progressionHistory of pyelonephritisAsymptomatic bacteriuriaChronic hypertensionMedian LOSObstetric outcomesUrinary culturePostpartum dataRetrospective cohortSecondary outcomesTract infectionsPrenatal Treatment of Congenital Cytomegalovirus With Valganciclovir: A Case Report
DeNoble AE, Saccoccio FM, Permar SR, Hughes BL. Prenatal Treatment of Congenital Cytomegalovirus With Valganciclovir: A Case Report. Clinical Infectious Diseases 2020, 71: 2506-2508. PMID: 32198512, DOI: 10.1093/cid/ciaa305.Peer-Reviewed Original ResearchMeSH KeywordsCytomegalovirusCytomegalovirus InfectionsFemaleFetal DiseasesHumansPregnancyPregnancy Complications, InfectiousValganciclovirConceptsCommon congenital infectionCongenital CMV infectionCases of hydropsCongenital cytomegalovirusCongenital infectionCMV infectionNeonatal treatmentNeurologic injuryCCMV infectionInfectious causesCase reportFetal anomaliesPrenatal treatmentTreatment strategiesMinimal sequelaeCytomegalovirusInfectionValganciclovirTreatmentSequelaeHydropsPregnancyInjury